---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-043239"
form_type: "8-K"
ticker: "NMTC"
cik: "0001500198"
company_name: "NEUROONE MEDICAL TECHNOLOGIES Corp"
filed_at: "2026-04-14T23:59:59+00:00"
generated_at: "2026-05-15T06:22:08.102423+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# NeuroOne to effect 1-for-6 reverse stock split to regain Nasdaq compliance

## Summary
- Board approved 1-for-6 reverse stock split, effective 5:00 p.m. ET on April 15, 2026.
- Trading on Nasdaq will commence on split-adjusted basis under symbol NMTC on April 16, 2026.
- No fractional shares; stockholders entitled to cash payment for fractional interests.
- Reverse split intended to increase bid price and regain compliance with Nasdaq minimum bid rule.
- Authorized shares and par value unchanged; CUSIP changes to 64130M308.

## SEC filing metadata
- accession: 0001213900-26-043239
- form_type: 8-K
- ticker: NMTC
- cik: 0001500198
- company_name: NEUROONE MEDICAL TECHNOLOGIES Corp
- filed_at: 2026-04-14T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1500198/000121390026043239/0001213900-26-043239-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1500198/000121390026043239/ea0286106-8k_neuroone.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-043239
- JSON: https://secwatch.observer/filing/0001213900-26-043239.json
- Plain text: https://secwatch.observer/filing/0001213900-26-043239.txt

## Source-grounded claims
- claim_id: 09d7bdd4d354c499a5343381de8ce7acc9b7c39f
  claim: NEUROONE MEDICAL TECHNOLOGIES Corp: Certificate of Amendment filed to effect a 1-for-6 reverse stock split of common stock (effective 2026-04-15).
  evidence_excerpt: On April 14, 2026, NeuroOne Medical Technologies Corporation (the “Company” or “NeuroOne”) filed an amendment to its Amended and Restated Certificate of Incorporation, as amended and/or restated from time to time, to effectuate a reverse stock split of the Company’s issued and outstanding shares of common stock, par value $0.001 per share (the “Common Stock”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1500198/000121390026043239/0001213900-26-043239-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.